Skip to content

AMPK/mTOR/ULK1 Signaling Mediates NCOA4-Dependent Ferritinophagy in BPA-Induced Ferroptosis in HT-22 Hippocampal Neuronal Cells.

Aug 2026 · Toxicology Letters · pp. 113183 · 0 citations · 44 references
Medicine

TL;DR

It is demonstrated that BPA activates the AMPK/mTOR/ULK1 signaling pathway to promote NCOA4‑mediated ferritinophagy, leading to ferroptosis in HT‑22 cells.

Abstract

Bisphenol A (BPA), a widespread environmental endocrine disruptor, is associated with neurodevelopmental disorders and induces oxidative neurotoxicity. Ferroptosis, an iron-dependent cell death driven by lipid peroxidation, has been implicated in toxicant‑induced neuronal injury. However, whether BPA triggers neuronal ferroptosis through autophagy remains unclear. Using HT‑22 hippocampal neuronal cells as an in vitro model, we investigated the role of autophagy‑dependent ferroptosis in BPA neurotoxicity. BPA exposure caused oxidative damage and mitochondrial ultrastructural abnormalities. It also induced ferroptosis‑related changes, including increased malondialdehyde (MDA), prostaglandin endoperoxide synthase 2 (PTGS2) protein expression, and reactive oxygen species (ROS), as well as decreased glutathione (GSH), glutathione peroxidase 4 (GPX4), and solute carrier family 7 member 11 (SLC7A11). These effects were reversed by the ferroptosis inhibitors ferrostatin-1 (Fer-1) and deferoxamine (DFO). Pharmacological inhibition of autophagy with chloroquine (CQ) also reversed BPA-induced GPX4/SLC7A11 downregulation and PTGS2 upregulation. Notably, BPA decreased the expressions of nuclear receptor coactivator 4 (NCOA4) and ferritin heavy chain 1 (FTH1), which was blocked by CQ. Knockdown of NCOA4 attenuated BPA-induced FTH1 and GPX4 loss, and PTGS2 elevation, indicating that NCOA4-mediated ferritinophagy is required for BPA-induced ferroptosis. Mechanistically, BPA activated AMPK/ULK1 axis while inhibiting mTOR; silencing of AMPK or ULK1 partially abrogated BPA-induced autophagy and ferroptosis. Collectively, these findings demonstrate that BPA activates the AMPK/mTOR/ULK1 signaling pathway to promote NCOA4‑mediated ferritinophagy, leading to ferroptosis in HT‑22 cells. This study provides a novel insight into the molecular mechanisms underlying BPA-associated neurotoxicity.

View source

Similar papers

Open access Jul 2026

Energy stress activates AMPK to suppress ferroptosis in neurodegenerative proteinopathies

Consistently, 2DG or liproxstatin-1 reduced ferroptosis-associated oxidative damage and improved behavioral or cognitive deficits in transgenic C. elegans, supporting a substantial contribution of AMPK-ACC1-associated signaling to ferroptosis suppression under energy stress.

Yuanyuan Yong, Yu-Xin Hu, Qian Feng et al. · 0 citations
Open access Jul 2026

Empagliflozin Attenuates Ferroptosis in Acute Myocardial Infarction via the AMPK/NRF2/SLC7A11 Signaling Pathway.

Investigating whether empagliflozin suppresses ferroptosis in acute myocardial infarction via the AMP-activated protein kinase (AMPK)/nuclear factor erythroid 2-related factor 2 (NRF2)/solute carrier family 7 member 11 (SLC7A11) pathway found it suppressed ferroptosis and ameliorated cellular injury in H/R-injured card...

Xiang-Rui Tang, Xiaoxia Zhao, Chunjun Liu · 0 citations
Jul 2026

Mangiferin Attenuates Aflatoxin B1-Induced Ferroptosis by Activating of Nrf2-Signaling and Mitochondrial Biogenesis in Human Ovarian Granulosa Cells.

The mechanisms by which MA attenuates AFB1-induced oxidative stress and ferroptosis in granulosa cells through the activation of Nrf2 signaling and mitochondrial biogenesis are examined, highlighting the potential of MA as a nutraceutical candidate for alleviating AFB1-induced granulosa cell toxicity.

Chi-Wai Ruan, Hsin-Yi Tsai, Chih-Hsin Hung et al. · 0 citations
Open access Jul 2026

L-2-Hydroxyglutarate sensitizes ferroptosis through ATF3/CHAC1-mediated glutathione degradation in hepatocellular carcinoma

The L2HGDH-L2HG axis is identified as a previously unrecognized metabolic checkpoint controlling ferroptosis sensitivity in liver cancer and glutathione degradation is uncovers as a therapeutically exploitable vulnerability for ferroptosis-based treatment strategies in HCC.

Cai-Xia Xi, Jun-Feng Pang, Mohammad Oliaeimotlagh et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.